Most Popular
1. It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- Gary_Tanashian
2.Stock Market Presidential Election Cycle Seasonal Trend Analysis - Nadeem_Walayat
3. Bitcoin S&P Pattern - Nadeem_Walayat
4.Nvidia Blow Off Top - Flying High like the Phoenix too Close to the Sun - Nadeem_Walayat
4.U.S. financial market’s “Weimar phase” impact to your fiat and digital assets - Raymond_Matison
5. How to Profit from the Global Warming ClImate Change Mega Death Trend - Part1 - Nadeem_Walayat
7.Bitcoin Gravy Train Trend Forecast 2024 - - Nadeem_Walayat
8.The Bond Trade and Interest Rates - Nadeem_Walayat
9.It’s Easy to Scream Stocks Bubble! - Stephen_McBride
10.Fed’s Next Intertest Rate Move might not align with popular consensus - Richard_Mills
Last 7 days
Friday Stock Market CRASH Following Israel Attack on Iranian Nuclear Facilities - 19th Apr 24
All Measures to Combat Global Warming Are Smoke and Mirrors! - 18th Apr 24
Cisco Then vs. Nvidia Now - 18th Apr 24
Is the Biden Administration Trying To Destroy the Dollar? - 18th Apr 24
S&P Stock Market Trend Forecast to Dec 2024 - 16th Apr 24
No Deposit Bonuses: Boost Your Finances - 16th Apr 24
Global Warming ClImate Change Mega Death Trend - 8th Apr 24
Gold Is Rallying Again, But Silver Could Get REALLY Interesting - 8th Apr 24
Media Elite Belittle Inflation Struggles of Ordinary Americans - 8th Apr 24
Profit from the Roaring AI 2020's Tech Stocks Economic Boom - 8th Apr 24
Stock Market Election Year Five Nights at Freddy's - 7th Apr 24
It’s a New Macro, the Gold Market Knows It, But Dead Men Walking Do Not (yet)- 7th Apr 24
AI Revolution and NVDA: Why Tough Going May Be Ahead - 7th Apr 24
Hidden cost of US homeownership just saw its biggest spike in 5 years - 7th Apr 24
What Happens To Gold Price If The Fed Doesn’t Cut Rates? - 7th Apr 24
The Fed is becoming increasingly divided on interest rates - 7th Apr 24
The Evils of Paper Money Have no End - 7th Apr 24
Stock Market Presidential Election Cycle Seasonal Trend Analysis - 3rd Apr 24
Stock Market Presidential Election Cycle Seasonal Trend - 2nd Apr 24
Dow Stock Market Annual Percent Change Analysis 2024 - 2nd Apr 24
Bitcoin S&P Pattern - 31st Mar 24
S&P Stock Market Correlating Seasonal Swings - 31st Mar 24
S&P SEASONAL ANALYSIS - 31st Mar 24
Here's a Dirty Little Secret: Federal Reserve Monetary Policy Is Still Loose - 31st Mar 24
Tandem Chairman Paul Pester on Fintech, AI, and the Future of Banking in the UK - 31st Mar 24
Stock Market Volatility (VIX) - 25th Mar 24
Stock Market Investor Sentiment - 25th Mar 24
The Federal Reserve Didn't Do Anything But It Had Plenty to Say - 25th Mar 24

Market Oracle FREE Newsletter

How to Protect your Wealth by Investing in AI Tech Stocks

Mass Psychology in Action; Instead of Selling Gilead it is Time to Take a Closer Look

Stock-Markets / Financial Markets 2016 Sep 20, 2016 - 03:12 PM GMT

By: Sol_Palha

Stock-Markets

"A little and a little, collected together, becomes a great deal; the heap in the barn consists of single grains, and drop and drop make the inundation." ~ Saadi

One should be wary of listening to individuals that claim to be experts especially if they are associated with big investment firms or popular media. In most instances, the word expert is the code word for jackass, and the word sell is the secret code word for buy, especially if these jackasses are the ones telling you to do so. Before we continue, let's examine the story below, and it clearly illustrates how those with the mass mindset sell when it is time to buy and buy when its time to sell.


Investors once OK with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress.There was a time when the underperformance of Gilead Sciences' (GILD) stock price was viewed as an opportunity to buy shares of a historically great biotech company at a discount.

But Gilead's stock price continues to fall, trading today where it did two years ago. The value play looks more like a trap. Investors once okay with waiting patiently for a Gilead rebound are growing frustrated, even angry, at the company's lack of progress. (I wrote about the challenges to Gilead's M&A growth strategy in July.)It's reaching the point now where Gilead CEO John Milligan (and before him, John Martin) is at risk of losing his perennial status as biotech's best, most trusted CEO.

"Investors have broadly lost confidence in management's ability to navigate the future competitive landscapes for its businesses and create value," wrote Piper Jaffray biotech analyst Josh Schimmer, in a research note on Gilead published this week. ~ Full Story

Look at the sentences that are boldfaced;  you can see the mass mindset in play. When we spot something like this, it starts to perk our interests as it usually signifies a bottom is close at hand.

Gilead Sciences Weekly Chart

The chatter will probably increase before a bottom takes hold but at this point, those closing out their positions will probably regret this decision in the months and years to come. What these individuals forget is that nothing can trend up forever and this chart clearly illustrates that this stock has had a spectacular run. Thus the current consolidation is a long-term bullish development. The stock is letting out a well-deserved dose of steam and slowly building momentum for the next upward leg.

There are two levels of support one that comes into play at; the first one falls in the 73.00-75.00 ranges, and the second one falls in the 63.00-65.00 ranges. The second zone offers a stronger floor of support and would make a safer entry point.

The five-year chart below illustrates that both the RSI and MACD's are trading in the oversold ranges. While this does not mean that the stock has put in a bottom, it does indicate that the downside is going to be limited from here.

Gilead Sciences Weekly Chart 2

Watch how the stock reacts on a test of 75.00; if it closes below this level on a weekly basis, then it is likely to test the 65.00 ranges.  One idea would be to spread your money over various entry points which will help reduce your overall cost and won't have you looking over your shoulder each step of the way.

Conclusion

Nature created the masses to serve as cannon fodder, and no matter what is done, nothing will change this. History is replete with examples of individuals who tried to help the masses; their only reward, in general, was the gallows or the bullet, depending on the era.  It comes down to perception; you cannot force someone to latch on to yours and vice versa.  This is why despite being one of the most hated bull markets in history, this bull market continues to trend higher because the masses refuse to embrace it. Thus consider this information as food for thought and not a recommendation to jump in and buy the stock.

Mass Psychology differs from contrarian investing; the driving force in Mass Psychology is that the focus is on extreme states. Contrarian investors tend to take an opposing position the moment the masses embrace a concept or market.  Mass psychology does not follow that mandate; we wait for extreme conditions (panic or euphoria) before taking an opposing position.

While fear levels are rising, GILD probably needs to experience one more stage of selling before the masses move into the panic zone. This will likely coincide with a move to the 63-65 ranges. Gilead has shed roughly 35% from its high set in June 2015, so at this stage, you nee to ask yourself if it makes sense to sell

"Big shots are only little shots who keep shooting." ~ Christopher Morley

by Sol Palha

www.tacticalinvestor.com

Sol Palha is a market analyst and educator who uses Mass Psychology, Technical Analysis and Esoteric Cycles to keep you on the right side of the market. He and his partners are on the web at www.tacticalinvestor.com.

© 2016 Copyright Sol Palha- All Rights Reserved

Disclaimer: The above is a matter of opinion provided for general information purposes only and is not intended as investment advice. Information and analysis above are derived from sources and utilising methods believed to be reliable, but we cannot accept responsibility for any losses you may incur as a result of this analysis. Individuals should consult with their personal financial advisors.


© 2005-2022 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in